Bachem Holding AG
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients (APIs). The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of BANB-SW would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1998) — listing | $305,172 7.2× | $437,098 7.2× |
| Year 6 (2003) | $245,890 6.9× | $353,644 6.9× |
| Year 11 (2008) | $169,223 6.1× | $245,694 6.1× |
| Year 16 (2013) | $87,372 4.3× | $127,843 4.3× |
| Year 21 (2018) | $22,070 1.7× | $32,307 1.8× |
| Year 26 (2023) | $6,253 1.2× | $9,192 1.2× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Bubendorf, Switzerland
Popular scenarios with BANB
For illustration only — not investment advice. Past performance is not indicative of future results.